160 related articles for article (PubMed ID: 22958059)
1. Non-invasive identification of melanoma with near-infrared and skin impedance spectroscopy.
Bodén I; Nyström J; Lundskog B; Zazo V; Geladi P; Lindholm-Sethson B; Naredi P
Skin Res Technol; 2013 Feb; 19(1):e473-8. PubMed ID: 22958059
[TBL] [Abstract][Full Text] [Related]
2. Near infrared and skin impedance spectroscopy - a possible support in the diagnostic process of skin tumours in primary health care.
Hägerlind E; Falk M; Löfstedt T; Lindholm-Sethson B; Bodén I
Skin Res Technol; 2015 Nov; 21(4):493-9. PubMed ID: 25773339
[TBL] [Abstract][Full Text] [Related]
3. Epiluminescence microscopy features of cutaneous malignant melanoma metastases.
Schulz H
Melanoma Res; 2000 Jun; 10(3):273-80. PubMed ID: 10890382
[TBL] [Abstract][Full Text] [Related]
4. Improving the diagnostic accuracy of dysplastic and melanoma lesions using the decision template combination method.
Faal M; Miran Baygi MH; Kabir E
Skin Res Technol; 2013 Feb; 19(1):e113-22. PubMed ID: 22672787
[TBL] [Abstract][Full Text] [Related]
5. Melanoma versus dysplastic naevi: microtopographic skin study with noninvasive method.
Mazzarello V; Soggiu D; Masia DR; Ena P; Rubino C
J Plast Reconstr Aesthet Surg; 2006; 59(7):700-5. PubMed ID: 16782565
[TBL] [Abstract][Full Text] [Related]
6. Electrical impedance spectroscopy as a potential adjunct diagnostic tool for cutaneous melanoma.
Mohr P; Birgersson U; Berking C; Henderson C; Trefzer U; Kemeny L; Sunderkötter C; Dirschka T; Motley R; Frohm-Nilsson M; Reinhold U; Loquai C; Braun R; Nyberg F; Paoli J
Skin Res Technol; 2013 May; 19(2):75-83. PubMed ID: 23350668
[TBL] [Abstract][Full Text] [Related]
7. Dysplastic naevus vs. in situ melanoma: digital dermoscopy analysis.
Burroni M; Sbano P; Cevenini G; Risulo M; Dell'eva G; Barbini P; Miracco C; Fimiani M; Andreassi L; Rubegni P
Br J Dermatol; 2005 Apr; 152(4):679-84. PubMed ID: 15840098
[TBL] [Abstract][Full Text] [Related]
8. Electrical impedance spectroscopy and the diagnostic accuracy for malignant melanoma.
Aberg P; Birgersson U; Elsner P; Mohr P; Ollmar S
Exp Dermatol; 2011 Aug; 20(8):648-52. PubMed ID: 21539620
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous dysplastic naevi in uveal melanoma patients: markers for prognosis?
Tóth-Molnár E; Hammer H; Oláh J
Melanoma Res; 2000 Feb; 10(1):36-9. PubMed ID: 10711638
[TBL] [Abstract][Full Text] [Related]
10. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
[TBL] [Abstract][Full Text] [Related]
11. Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues.
Hussein MR
J Clin Pathol; 2005 May; 58(5):453-6. PubMed ID: 15858113
[TBL] [Abstract][Full Text] [Related]
12. Simulators of malignant melanoma of the skin.
Cerroni L; Kerl H
Eur J Dermatol; 1998 Sep; 8(6):388-96. PubMed ID: 9729049
[TBL] [Abstract][Full Text] [Related]
13. The value of cyclooxygenase-2 expression in differentiating between early melanomas and histopathologically difficult types of benign human skin lesions.
Kuźbicki Ł; Lange D; Strączyńska-Niemiec A; Chwirot BW
Melanoma Res; 2012 Feb; 22(1):70-6. PubMed ID: 22228276
[TBL] [Abstract][Full Text] [Related]
14. Lentiginous melanoma.
Weedon D
J Cutan Pathol; 2009 Nov; 36(11):1232. PubMed ID: 19719833
[No Abstract] [Full Text] [Related]
15. Malignant melanoma, dysplastic melanocytic nevi, and Spitz tumors. Histologic classification and characteristics.
Barnhill RL
Clin Plast Surg; 2000 Jul; 27(3):331-60, viii. PubMed ID: 10941557
[TBL] [Abstract][Full Text] [Related]
16. Increased diagnosis of thin superficial spreading melanomas: A 20-year study.
Frangos JE; Duncan LM; Piris A; Nazarian RM; Mihm MC; Hoang MP; Gleason B; Flotte TJ; Byers HR; Barnhill RL; Kimball AB
J Am Acad Dermatol; 2012 Sep; 67(3):387-94. PubMed ID: 22153791
[TBL] [Abstract][Full Text] [Related]
17. [Nevus associated malignant melanomas--diagnostic validation and prognosis].
Stadler R; Garbe C
Hautarzt; 1991 Jul; 42(7):424-9. PubMed ID: 1938395
[TBL] [Abstract][Full Text] [Related]
18. [Nevus and malignant cutaneous melanoma].
Morales Suárez-Varela MM; Llopis González A; Lacasaña Navarro M; Ferrándiz Ferragud J
Rev Sanid Hig Publica (Madr); 1991; 65(3):233-8. PubMed ID: 1801183
[TBL] [Abstract][Full Text] [Related]
19. Childhood malignant melanoma in a patient with dysplastic nevi.
Wagner RF
Tex Med; 1992 Jan; 88(1):72-3. PubMed ID: 1557705
[TBL] [Abstract][Full Text] [Related]
20. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
Boyd AS; Shakhtour B; Shyr Y
J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
